Post job

Alnylam Pharmaceuticals overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
1,323
Founded in
Website
Organization type
Public
Social media
Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
Founded in 2002, Alnylam Pharmaceuticals is an established company that loves to hire graduates from Northeastern University, with 23.7% of its employees having attended Northeastern University. Alnylam Pharmaceuticals has established itself as a great place to work in Massachusetts, and it is number 7 on Zippia's list of Best Companies to Work for in Cambridge, MA.The average employee at Alnylam Pharmaceuticals makes $81,014 per year. Pay at Alnylam Pharmaceuticals is significantly lower than some of its highest paying competitors, like Gilead Sciences, Acorda Therapeutics, and Vertex Pharmaceuticals, which pay $99,828, $97,279, and $95,952, respectively.
Based in Cambridge, MA, Alnylam Pharmaceuticals is a key player in the pharmaceutical industry with 1,323 employees and an annual revenue of $2.2B.

Alnylam Pharmaceuticals's mission statement

Build an independent, top-tier biopharmaceutical company founded on RNAi.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration

3.0/5

Alnylam Pharmaceuticals employee reviews

Based on 1 ratings

Do you work at Alnylam Pharmaceuticals?

Help job seekers learn about working at Alnylam Pharmaceuticals

On this page

Be the first to review Alnylam Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Alnylam Pharmaceuticals?

The team at Alnylam Pharmaceuticals

  • The founders of Alnylam Pharmaceuticals are Amy W. Schulman, Phillip A. Sharp, John K. Clarke, David Bartel, Paul Schimmel, Phillip Zamore, Robert Langer and Thomas Tuschl.
  • The key people at Alnylam Pharmaceuticals are Yvonne L. Greenstreet, Amy W. Schulman and Phillip A. Sharp.
Key people
Yvonne L. Greenstreet
Amy W. Schulman
Phillip A. Sharp
John K. Clarke
David Bartel
Paul Schimmel
Phillip Zamore
Robert Langer
Thomas Tuschl

Alnylam Pharmaceuticals rankings

Alnylam Pharmaceuticals is ranked #62 on the Best Pharmaceutical companies to work for in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Alnylam Pharmaceuticals salaries

Average Alnylam Pharmaceuticals salary
$81,014
yearly
$38.95 hourly
Updated March 14, 2024

Rate the fairness of Alnylam Pharmaceuticals' compensation policies.

Zippia waving zebra

Alnylam Pharmaceuticals diversity

9.1
Diversity score
We calculated Alnylam Pharmaceuticals’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Alnylam Pharmaceuticals’s workforce.
Alnylam Pharmaceuticals diversity summary. Zippia estimates Alnylam Pharmaceuticals's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Alnylam Pharmaceuticals's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Alnylam Pharmaceuticals's workforce.
  • Alnylam Pharmaceuticals has 1,323 employees.
  • 51% of Alnylam Pharmaceuticals employees are women, while 49% are men.
  • The most common ethnicity at Alnylam Pharmaceuticals is White (59%).
  • 16% of Alnylam Pharmaceuticals employees are Asian.
  • 14% of Alnylam Pharmaceuticals employees are Hispanic or Latino.
  • The average employee at Alnylam Pharmaceuticals makes $81,014 per year.
  • Alnylam Pharmaceuticals employees are most likely to be members of the democratic party.
  • Employees at Alnylam Pharmaceuticals stay with the company for 4.2 years on average.

Do you work at Alnylam Pharmaceuticals?

Is Alnylam Pharmaceuticals' workforce diverse and inclusive?

Alnylam Pharmaceuticals financial performance

9.8
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Alnylam Pharmaceuticals currently has 1.0B in revenue. Alnylam Pharmaceuticals's most recent quarter produced 750.5m (q3'2023).

Alnylam Pharmaceuticals annual revenue

$2B
$2B
$1B
$899M
$450M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024

Highest paying Alnylam Pharmaceuticals competitors

Compare Alnylam Pharmaceuticals salaries to competitors, including Gilead Sciences, Acorda Therapeutics, and Vertex Pharmaceuticals. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Acorda Therapeutics average $97,279 per year, and the salaries at Vertex Pharmaceuticals come in at $95,952 per year.
RankCompanyAverage salaryJobs
1$99,8280
2$97,2790
3$95,9520
4$94,9850
5$93,8860
6$92,9860
7$91,9010
8$90,3280
9$90,1700
10$85,5890

Are you an executive, HR leader, or brand manager at Alnylam Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Alnylam Pharmaceuticals FAQs

Search for jobs

Most common locations at Alnylam Pharmaceuticals

Zippia gives an in-depth look into the details of Alnylam Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alnylam Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Alnylam Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alnylam Pharmaceuticals. The data presented on this page does not represent the view of Alnylam Pharmaceuticals and its employees or that of Zippia.

Alnylam Pharmaceuticals may also be known as or be related to Alnylam Pharmaceuticals, Alnylam Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc. and Alnylam Pharmaceuticals, Inc.